Author： Barrero Maria J.
Publisher： MDPI
E-ISSN： 1422-0067|18|6|1108-1108
ISSN： 1422-0067
Source： International Journal of Molecular Sciences, Vol.18, Iss.6, 2017-05, pp. : 1108-1108
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Recently, immunotherapeutic approaches have shown impressive responses in a subset of cancer patients. However, the rate of success is low and a large percentage of treated patients do not experience clinical benefits. Therefore, additional strategies are needed to improve responses and select responsive patients. Emerging data suggest that epigenetic drugs can improve the responses to immunotherapy. Understanding the mechanisms of resistance to immunotherapy and the epigenetic events that take place during immune evasion is critical to providing a rational combined use of immunotherapies and epigenetic drugs. This review focuses in the epigenetic mechanisms involved in the responses to immunotherapy and how current drugs that target epigenetic regulators impact on them.
Related content
Access to resources
Recommend
Exploiting Epigenetic Alterations in Prostate Cancer
By Baumgart Simon J. Haendler Bernard
International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. :
Epigenetic Bases of Aberrant Glycosylation in Cancer
By Dall’Olio Fabio Trinchera Marco
International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. :